The CDC reports an increase in respiratory syncytial virus (RSV) cases among young children and babies; the deadline looms for reauthorizing the United States’ global AIDS program as it has become a topic within the abortion debate; an eye-tracking device may help to diagnose autism spectrum disorder earlier.
RSV Cases Rise Among Young Children and Babies
The CDC has alerted doctors about a rise in respiratory syncytial virus (RSV) cases among young children and babies in Georgia and Florida, according to CNN. The late-summer increase suggests that RSV is falling into a typical seasonal pattern after several years of early viral activity caused by the pandemic. The CDC reported that from August 5 to 19, RSV-related hospitalizations increased from 2 in 100,000 kids aged 4 and younger to 7 per 100,000, the majority of which were in babies younger than 1 year. Doctors have been advised by the CDC to be ready with a new RSV vaccine for young children to help prevent them from developing the infection.
Global AIDS Program Deadline Looms With No Deal in Sight
Congress is likely to blow past a September 30 deadline to reauthorize the law that governs PEPFAR (President's Emergency Plan for AIDS Relief), the United States’ global HIV/AIDS relief work, as it has become a topic within the fight over abortion, according to Politico. Members of both parties do not see a clear path to reviving the law by the end of the year because of competing interests. For example, Republican House members and conservative advocates allege that some of PEPFAR’s annual budget of nearly $7 billion flows to abortion providers, which the Biden administration, program leaders, and outside experts deny.
Potential Earlier Autism Diagnosis With Eye-Tracking Device
A device that follows kids’ eye movements while watching a video of 2 children interacting may help diagnose autism spectrum disorder earlier, according to NBC News. Studies suggest that the tablet-based device can identify autism in children aged 16 to 30 months as accurately as a specialist. It monitors the video viewer’s eye movements at a rate of 120 times a second, allowing specialists to determine what social information children are taking in; typically developing children focus on the interaction while those with autism focus on other spots in the video. With this device, results can be available in 30 minutes.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More